Cargando…
Prolonged severe neutropenia after the first daratumumab administration for multiple myeloma with baseline neutropenia
Autores principales: | Nakamura, Fumihiko, Nasu, Ryo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6700049/ https://www.ncbi.nlm.nih.gov/pubmed/31098738 http://dx.doi.org/10.1007/s00277-019-03711-0 |
Ejemplares similares
-
Terbinafine and Neutropenia
por: Yavaşoğlu, İrfan
Publicado: (2015) -
Daratumumab in dialysis-dependent multiple myeloma
por: Jeyaraman, Preethi, et al.
Publicado: (2020) -
Fluoxetine-induced neutropenia
por: Bavle, A.
Publicado: (2012) -
Managing neutropenia by pegfilgrastim in patients affected by relapsed/refractory multiple myeloma treated with bendamustine-bortezomib-dexamethasone
por: Cerchione, Claudio, et al.
Publicado: (2016) -
Poor response to daratumumab and carfilzomib in newly diagnosed anaplastic multiple myeloma
por: Saburi, Masuho, et al.
Publicado: (2020)